Galante Joseph C 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Mar 27, 2023
Insider Transaction Report
Form 4
Galante Joseph C
Director
Transactions
- Award
Common Stock
2023-03-24$1.92/sh+1,000$1,920→ 58,356 total
Footnotes (1)
- [F1]Restricted stock award will vest 100% on March 24, 2024.